Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 155 (RNA5SP155)

Target: RNA5SP155
Molecular classification: Non-coding RNA pseudogene, rRNA pseudogene

Overview

RNA, 5S ribosomal pseudogene 155 (RNA5SP155) represents a non-coding RNA locus classified as an rRNA pseudogene. Unlike functional 5S ribosomal RNA, which is a core structural and functional component of the ribosome in protein synthesis[1][3][5], pseudogenes like RNA5SP155 are nonfunctional gene remnants produced by genome duplication or retrotransposition and do not encode active RNAs or proteins. The 5S rRNA parent gene is highly conserved and integral to ribosome stability and function but this pseudogene does not participate in those cellular processes and does not act as a molecular target in disease or therapy[2][4].

Other names: RNA5SP155RN5S155RNA, 5S ribosomal 155

Mechanism of action

None; there are no mechanisms of action described for drugs targeting this pseudogene.

Biological functions

None known; as a pseudogene, RNA5SP155 does not have experimentally validated biological functions. Functional 5S rRNA (not pseudogenes) is involved in ribosome assembly and translation, but this pseudogene does not contribute to those processes[4][2][3].

Disease associations

None documented for RNA5SP155 specifically.Some transcribed pseudogenes may play regulatory roles via competitive endogenous RNA (ceRNA) networks in cancer, but there is no evidence for such a role in RNA5SP155 itself[8].

Safety considerations

None; RNA5SP155 is not a therapeutic or diagnostic target.

Interacting drugs

None known; no drugs are documented to interact with RNA5SP155.

Biomarkers

None; RNA5SP155 is not used as a biomarker for patient selection or monitoring.

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 155 (RNA5SP155).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 155 (RNA5SP155).

Explore the full profile